Clinical Pharmacology Advances and Applications
译名:临床药理学:进展与应用
Clinical Pharmacology-Advances and Applications
1-3
2026
影响因子区间
—
平台估算
30%
2025
中国作者发文占比
3300 USD
收费
期刊简介:Clinical Pharmacology: Advances and Applications is an international, peer-reviewed, open access, online journal, that focuses on the publication of Clinical Trials and Study protocols with a special interest in pharmacologic behavior of drugs and agents. The journal aims to serve both the academic and industrial communities and it is dedicated to publishing rapidly all scientifically sound Clinical Trials and Study protocols. Clinical Trials submitted to the journal should report detailed pharmacologic information/data. The journal aims at publishing articles that will allow predictions to be made from drug chemistry and pharmacology for eventual benefits and side effects. Clinical Pharmacology: Advances and Applications provides the best available evidence to support decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by patients. The journal considers original research, study protocols, methodology papers, short reports, reviews and commentaries in all areas of drug experience in humans. Clinical Pharmacology: Advances and Applications will no longer consider meta-analyses for publication.
【译文】《临床药理学:进展与应用》是一本国际性、同行评审、开放获取的在线期刊,专注于出版临床试验和研究方案,特别关注药物和制剂的药理行为。该杂志旨在为学术界和工业界服务,致力于快速出版所有科学合理的临床试验和研究方案。提交给期刊的临床试验应报告详细的药理学信息/数据。该杂志的目标是发表文章,以便从药物化学和药理学中预测最终的益处和副作用。临床药理学:进展和应用提供了最佳的现有证据,以支持与患者使用的疫苗、药物和医疗器械的安全性和有效性相关的决策。该杂志考虑了人类药物体验所有领域的原创研究、研究方案、方法论论文、简短报告、评论和评论。临床药理学:进展和应用将不再考虑发表荟萃分析。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |